Your browser doesn't support javascript.
loading
TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor.
Jo, Ukhyun; Murai, Yasuhisa; Agama, Keli K; Sun, Yilun; Saha, Liton Kumar; Yang, Xi; Arakawa, Yasuhiro; Gayle, Sophia; Jones, Kelli; Paralkar, Vishwas; Sundaram, Ranjini K; Van Doorn, Jinny; Vasquez, Juan C; Bindra, Ranjit S; Choi, Woo Suk; Pommier, Yves.
Afiliación
  • Jo U; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Murai Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Agama KK; Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Sun Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Saha LK; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Yang X; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Arakawa Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Gayle S; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Jones K; Cybrexa Therapeutics, New Haven, Connecticut.
  • Paralkar V; Cybrexa Therapeutics, New Haven, Connecticut.
  • Sundaram RK; Cybrexa Therapeutics, New Haven, Connecticut.
  • Van Doorn J; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut.
  • Vasquez JC; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut.
  • Bindra RS; Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
  • Choi WS; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut.
  • Pommier Y; Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland.
Mol Cancer Ther ; 21(7): 1090-1102, 2022 07 05.
Article en En | MEDLINE | ID: mdl-35439320
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN-Topoisomerasas de Tipo I / Inhibidores de Topoisomerasa I / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN-Topoisomerasas de Tipo I / Inhibidores de Topoisomerasa I / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article